John Ivankoe

Q: What is John Ivankoe's success rate?

John Ivankoe currently has a success rate of 94.45990860243863.

Q: What is the average return of John Ivankoe's calls?

Their stock ratings have generated an average return of 13.0177783695658.

JP Morgan | Consumer Cyclical

John Ivankoe is an analyst from JP Morgan specializing in the Consumer Cyclical sector. Ranked #1583 out of 4635 analysts, they have issued 34 stock ratings with a success rate of 94.46% and an average return of 13.02%.

John Ivankoe has a well-established track record, with 34 ratings issued in the Consumer Cyclical sector. They have consistently delivered a success rate of 94.46% and an average return of 13.02%, underscoring their expertise and ability to identify winning opportunities for investors.

#1583

Out of 4635

Total Ratings

+94.46%

Success Rate

+13.02%

Average Return

Recent Ratings Analysis

SBUX

Buy

Apr 24, 2026

Target

$100.00

Current

$99.54

Performance

—

John Ivankoe rated SBUX as Overweight on Apr 24, 2026, setting a price target of 100. Shares have remained stable near 99.54, leaving the 100 target still in play.

QSR

Buy

Apr 24, 2026

Target

$80.00

Current

$81.23

Performance

—

On Apr 24, 2026, QSR was given a Overweight rating by John Ivankoe, with a target price of 80. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

DPZ

Buy

Apr 24, 2026

Target

$440.00

Current

$372.39

Performance

—

DPZ received a Overweight rating from John Ivankoe on Apr 24, 2026, aiming for 440. Price action was muted, as shares hovered around 372.39 despite the bullish outlook.

CAVA

Buy

Apr 24, 2026

Target

$90.00

Current

$93.11

Performance

—

On Apr 24, 2026, John Ivankoe published a Overweight outlook on CAVA, with a target of 90. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 93.11.

BLMN

Sell

Apr 24, 2026

Target

$6.00

Current

$6.39

Performance

—

John Ivankoe on Apr 24, 2026 assigned BLMN a Underweight rating, with a price target of 6. The bearish stance awaits confirmation while shares hold level at 6.39.

EAT

Buy

Mar 16, 2026

Target

$190.00

Current

$143.85

Performance

-0.16%

On Mar 16, 2026, John Ivankoe reaffirmed EAT with a Overweight rating, targeting 190. Market indecision has kept the 190 target in a holding pattern.

YUM

Buy

Feb 24, 2026

Target

$170.00

Current

$160.73

Performance

-3.15%

YUM was rated Overweight by John Ivankoe on Feb 24, 2026, with a price objective of 170. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

MCD

Buy

Feb 24, 2026

Target

$325.00

Current

$302.53

Performance

-9.16%

On Feb 24, 2026, John Ivankoe initiated coverage on MCD with a Overweight rating and target of 325. The Buy call has yet to be validated as shares remain 22.47 away from the target.

SYY

Buy

Jan 28, 2026

Target

$87.00

Current

$75.81

Performance

-9.22%

John Ivankoe issued a Overweight recommendation for SYY on Jan 28, 2026, price target set at 87. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

WEN

Hold

Dec 03, 2025

Target

$12.00

Current

$6.93

Performance

-19.04%

On Dec 03, 2025, WEN was evaluated by John Ivankoe, who gave a Neutral rating and target of 12. The Hold call avoided chasing into subsequent weakness of 19.04%.

CAKE

Sell

Oct 30, 2025

Target

$52.00

Current

$61.88

Performance

26.00%

John Ivankoe rated CAKE as Underweight on Oct 30, 2025, setting a price target of 52. The bearish call was validated, as shares fell 26.00% to 61.88.

CMG

Hold

Oct 30, 2025

Target

$40.00

Current

$33.89

Performance

4.19%

On Oct 30, 2025, CMG was given a Neutral rating by John Ivankoe, with a target price of 40. Market indecision, reflected in sideways trading near 33.8945, supported the cautious call.

TXRH

Hold

Oct 07, 2025

Target

$182.00

Current

$160.44

Performance

-3.67%

TXRH received a Neutral rating from John Ivankoe on Oct 07, 2025, aiming for 182. Shares remained flat at 160.44, aligning with the neutral rating.

BRCB

Hold

Oct 07, 2025

Target

$24.00

Current

$12.70

Performance

-41.88%

On Oct 07, 2025, John Ivankoe published a Neutral outlook on BRCB, with a target of 24. Weakness in the stock, now at 12.7, supported the conservative rating.

DRI

Buy

Oct 06, 2025

Target

$230.00

Current

$202.34

Performance

4.69%

John Ivankoe on Oct 06, 2025 assigned DRI a Overweight rating, with a price target of 230. The recommendation remains pending validation as shares consolidate around 202.34.

SHAK

Sell

Jun 25, 2025

Target

$110.00

Current

$97.59

Performance

-27.12%

On Jun 25, 2025, John Ivankoe reaffirmed SHAK with a Underweight rating, targeting 110. The outlook was invalidated by a rebound to 97.59.

USFD

Hold

Jun 25, 2025

Target

$85.00

Current

$92.83

Performance

21.84%

USFD was rated Neutral by John Ivankoe on Jun 25, 2025, with a price objective of 85. Despite caution, upside momentum rewarded risk-takers with gains to 92.83.

BROS

Buy

Feb 13, 2025

Target

$80.00

Current

$54.54

Performance

-34.71%

On Feb 13, 2025, John Ivankoe initiated coverage on BROS with a Overweight rating and target of 80. The Buy call has yet to be validated as shares remain 25.46 away from the target.

Frequency Asked Questions

Who is John Ivankoe?

John Ivankoe is an analyst from JP Morgan specializing in the Consumer Cyclical sector.

What is John Ivankoe's success rate?

John Ivankoe currently has a success rate of +94.46%.

How many ratings has John Ivankoe issued?

John Ivankoe has issued 34 stock ratings so far.

What is the average return of John Ivankoe's calls?

Their stock ratings have generated an average return of +13.02%.

What is John Ivankoe's ranking?

John Ivankoe is ranked #1583 out of 4635 analysts.

What types of ratings does John Ivankoe give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow John Ivankoe?

You can follow John Ivankoe by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by John Ivankoe?

Their latest rating was a Buy on SBUX issued on 2026-04-24.